Literature DB >> 2984599

Postoperative prophylactic anticonvulsant therapy in cerebral gliomas.

D J Boarini, D W Beck, J C VanGilder.   

Abstract

A retrospective study was performed to evaluate the efficacy of prophylactic anticonvulsants in preventing seizures in 68 patients with supratentorial astrocytomas who had been treated with operation and irradiation and who had no previous history of convulsions. Thirty-three patients received prophylactic anticonvulsants and 38 patients did not. The incidence of all types of seizures (generalized convulsions or partial) was lower in patients receiving anticonvulsants. No seizures with an impairment of consciousness occurred in the patients with documented therapeutic anticonvulsant blood levels. The overall incidence of seizures was 39% in untreated patients and 21% in treated patients. The incidence of major seizures including tonic/clonic or partial complex seizures with impairment of consciousness was zero in patients with therapeutic anticonvulsant levels and 18% in untreated patients. Regarding the overall incidence of seizures in both groups, there tend to be fewer seizures in older patients, females, patients with a higher grade of malignancy, and patients who had a more radical resection of the tumor. This study suggests that seizures are a frequent occurrence after operation and irradiation for supratentorial glioma and that anticonvulsants may be effective in reducing the incidence of those seizures.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2984599     DOI: 10.1227/00006123-198503000-00002

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  23 in total

1.  Prevention of early postoperative seizures in patients with primary brain tumors: preliminary experience with oxcarbazepine.

Authors:  Anna Maria Mauro; Chiara Bomprezzi; Simonetta Morresi; Leandro Provinciali; Francesco Formica; Maurizio Iacoangeli; Massimo Scerrati
Journal:  J Neurooncol       Date:  2006-08-31       Impact factor: 4.130

Review 2.  Treatment of epileptic seizures in brain tumors: a critical review.

Authors:  R Bauer; M Ortler; M Seiz-Rosenhagen; R Maier; J V Anton; I Unterberger
Journal:  Neurosurg Rev       Date:  2014-04-24       Impact factor: 3.042

Review 3.  Medical management of patients with brain tumors.

Authors:  Patrick Y Wen; David Schiff; Santosh Kesari; Jan Drappatz; Debra C Gigas; Lisa Doherty
Journal:  J Neurooncol       Date:  2006-06-29       Impact factor: 4.130

4.  Factors involved in maintaining prolonged functional independence following supratentorial glioblastoma resection. Clinical article.

Authors:  Kaisorn L Chaichana; Aditya N Halthore; Scott L Parker; Alessandro Olivi; Jon D Weingart; Henry Brem; Alfredo Quinones-Hinojosa
Journal:  J Neurosurg       Date:  2010-06-04       Impact factor: 5.115

5.  Do we need seizure prophylaxis for brain tumor surgery?

Authors:  Mohamad Koubeissi
Journal:  Epilepsy Curr       Date:  2014-01       Impact factor: 7.500

Review 6.  Prophylactic anticonvulsants in patients with primary glioblastoma.

Authors:  Arvin R Wali; Robert C Rennert; Sonya G Wang; Clark C Chen
Journal:  J Neurooncol       Date:  2017-07-28       Impact factor: 4.130

7.  Antiepileptic drugs as prophylaxis for postcraniotomy seizures.

Authors:  Janette Greenhalgh; Jennifer Weston; Yenal Dundar; Sarah J Nevitt; Anthony G Marson
Journal:  Cochrane Database Syst Rev       Date:  2020-04-28

Review 8.  [Brain tumors and epilepsy].

Authors:  H Stefan; I Blümcke; M Buchfelder
Journal:  Nervenarzt       Date:  2005-10       Impact factor: 1.214

9.  Use of peri-operative anti-epileptic drugs in patients with newly diagnosed high grade malignant glioma: a single center experience.

Authors:  Shelly Lwu; Mark G Hamilton; Peter A Forsyth; J Gregory Cairncross; Ian F Parney
Journal:  J Neurooncol       Date:  2009-08-08       Impact factor: 4.130

10.  Seizures during the management of high-grade gliomas: clinical relevance to disease progression.

Authors:  Young-Hoon Kim; Chul-Kee Park; Tae Min Kim; Seung Hong Choi; Yu Jung Kim; Byung Se Choi; Jung Ho Han; Se-Hoon Lee; Chae-Yong Kim; In Ah Kim; Dae Seog Heo; Il Han Kim; Dong Gyu Kim; Hee-Won Jung
Journal:  J Neurooncol       Date:  2013-03-04       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.